(Q44813868)

English

High efficacy of 1-week doxycycline- and amoxicillin-based quadruple regimen in a culture-guided, third-line treatment approach for Helicobacter pylori infection

scientific article published in April 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

High efficacy of 1-week doxycycline- and amoxicillin-based quadruple regimen in a culture-guided, third-line treatment approach for Helicobacter pylori infection (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Helicobacter pylori

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Rossella Cianci

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

author name string

Cammarota G

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Martino A

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Pirozzi G

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Branca G

5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Nista EC

6

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Cazzato A

7

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Cannizzaro O

8

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Miele L

9

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Grieco A

10

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Gasbarrini A

11

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Gasbarrini G

12

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

language of work or name

0 references

publication date

1 April 2004

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

789-795

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Efficacy of a multistep strategy for Helicobacter pylori eradication.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01910.X

21 January 2018

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01910.X

21 January 2018

Efficacy and safety of single-triple capsules of bismuth biskalcitrate, metronidazole and tetracycline, given with omeprazole, for the eradication of Helicobacter pylori: an international multicentre study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01910.X

21 January 2018

Omeprazole triple therapy versus omeprazole quadruple therapy for healing duodenal ulcer and eradication of Helicobacter pylori infection: a 24-month follow-up study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01910.X

21 January 2018

A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: The QUADRATE Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01910.X

21 January 2018

Review article: the treatment of refractory Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01910.X

21 January 2018

Effectiveness of two quadruple, tetracycline- or clarithromycin-containing, second-line, Helicobacter pylori eradication therapies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01910.X

21 January 2018

A triple therapy regimen after failed Helicobacter pylori treatments

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01910.X

21 January 2018

Furazolidone-based triple 'rescue therapy' vs. quadruple 'rescue therapy' for the eradication of Helicobacter pylori resistant to metronidazole.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01910.X

21 January 2018

Treatment after failure: the problem of "non-responders".

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01910.X

21 January 2018

'Rescue' therapy with rifabutin after multiple Helicobacter pylori treatment failures

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01910.X

21 January 2018

A third-line levofloxacin-based rescue therapy for Helicobacter pylori eradication

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01910.X

21 January 2018

Impact of furazolidone-based quadruple therapy for eradication of Helicobacter pylori after previous treatment failures

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01910.X

21 January 2018

Comparison of the Etest and the NCCLS-approved agar dilution method to detect metronidazole and clarithromycin resistant Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01910.X

21 January 2018

Quadruple therapy containing amoxicillin and tetracycline is an effective regimen to rescue failed triple therapy by overcoming the antimicrobial resistance of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01910.X

21 January 2018

Clarithromycin vs. furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01910.X

21 January 2018

Salvage therapy after two or more prior Helicobacter pylori treatment failures: the super salvage regimen

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01910.X

21 January 2018

A prospective, randomized study of quadruple therapy and high-dose dual therapy for treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01910.X

21 January 2018

Amoxicillin/tetracycline combinations are inadequate as alternative therapies for Helicobacter pylori infection.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01910.X

21 January 2018

Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second-line treatment for Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01910.X

21 January 2018

Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: a randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01910.X

21 January 2018

Levofloxacin based triple therapy as a second-line treatment after failure of Helicobacter pylori eradication with standard triple therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01910.X

21 January 2018

Mixed-infection of antibiotic susceptible and resistant Helicobacter pylori isolates in a single patient and underestimation of antimicrobial susceptibility testing

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01910.X

21 January 2018

Identifiers

10.1111/J.1365-2036.2004.01910.X

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44813868&oldid=2046945303"